Purchasing & Suppliers
Purchasing at Boehringer Ingelheim
Search
Sustainable Development
Sustainable Development
Our Responsibility
Human Health Our Responsibility
Bondi Junction response must include increased funding and support for severe mental illness
Voters want pre-election commitments for severe mental illness
Empowering independence with Guide Dogs
Empowering independence with Guide Dogs
Drug Discovery at Boehringer Ingelheim
Find out more about the drug discovery process at Boehringer Ingelheim
He’s my dog, I’m his human
Getting a Guide Dog was a life-changing moment for Lucy, who lost her sight in a car accident as a teenager.
Early diagnosis and a positive outlook: Bill’s story
Early diagnosis and a positive outlook: Bill’s story
Micardis®
Treatment of hypertension. For the reduction of the risk of myocardial infarction (heart attack), stroke or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take A
The Angels Initiative Surpasses 1,000 Registrations for Acute Stroke Training
Global program equips HCPs for optimal acute stroke treatment
Keith's Journey with Heart of Australia
Rural and remote medical needs in Australia
Angels Initiative
Angels Initiative
TOP Employer 2023
TOP Employer 2023
Youth programs shape future farmers for success
Livestock producers in New Zealand are facing challenges that make it hard for the next generation to succeed as farmers. Rising costs, production pressures, and changes in industry practices are causing difficulties. However, a group of young farmers cal
Empowering People, Making a Difference
VTI Day is a special event in Boehringer Ingelheim's cultural calendar
Boehringer Ingelheim recognised as Top Employer for 2024
Boehringer Ingelheim Recognised as Top Employer for 2024, Demonstrating Strong Commitment to People Development in Australia and New Zealand